relationship

CCUSD - DEFENT / Defense Diagnostics Fentanyl-Test-Device Pilot

2025-12-09 2025-2026 Board-approved pilot announced December 2025
At a glance

CCUSD adopted a pilot in December 2025 to provide free pocket-sized fentanyl test devices to students and families. District communications confirm the Board action and Triston Ezidore's public support; contemporaneous reporting identifies DEFENT, a division of Defense Diagnostics Inc., as the partner and says the devices were provided free for the pilot.

School-district harm-reduction partnership / pilot CCUSD district communication and meeting video, corroborated by contemporaneous local/television reporting
What the record shows

Key facts

Amount
$0 reported cost for pilot devices
Financial context
Free pilot devices reported; no purchase price identified in reviewed sources
Documented amounts
Pilot devices reported as provided free
Board Action
Pilot adopted by the CCUSD Board on December 9, 2025.
Distribution
District communications initially identified Culver City Adult School among distribution locations.
Source Boundary
Vendor identity and free-device terms are corroborated by contemporaneous reporting; no personal financial connection to Ezidore is asserted.
Evidence

Sources

Navigate the archive

Linked records

Direct links named in this record: people, organizations, properties, projects, events and other canonical archive records.

More context

Related records

Ranked by documented overlap such as a shared project, property, person, organization, event, relationship, or an explicit link between records.

Archive indexing

Record tags

Use these archive labels to follow related people, organizations, subjects and records across Culver City Records.

Context note

CCUSD's own communication establishes the Board-adopted pilot and Ezidore's public support, while local and television reporting identify DEFENT/Defense Diagnostics and the free-device arrangement. CCR does not infer that Ezidore selected the vendor, negotiated terms or had any financial relationship with the company absent separate evidence.